PuSH - Publikationsserver des Helmholtz Zentrums München

Zeitschriften-Browsing

17 Datensätze gefunden.
Zum Exportieren der Ergebnisse bitte einloggen.
Alle Publikationen dieser Seite in den Korb legen
1.
Liang, R.* et al.: Clinical features, polysomnography, and genetics association study of restless legs syndrome in clinic based Chinese patients: A multicenter observational study. Sleep Med. 117, 123-130 (2024)
2.
Wang, M. et al.: Changes in sleep duration and sleep difficulties from adolescence to young adulthood and the risk of obesity: Bidirectional evidence in the GINIplus and LISA studies. Sleep Med. 101, 401-410 (2023)
3.
Johnson, J.M.* et al.: The effect of slow-wave sleep and rapid eye-movement sleep interventions on glycaemic control: A systematic review and meta-analysis of randomised controlled trials. Sleep Med. 92, 50-58 (2022)
4.
Tilch, E. et al.: ExomeChip-based rare variant association study in restless legs syndrome. Sleep Med. 94, 26-30 (2022)
5.
Negele, L.E. et al.: Association between objectively assessed physical activity and sleep quality in adolescence. Results from the GINIplus and LISA studies. Sleep Med. 72, 65-74 (2020)
6.
Allen, R.P.* et al.: Animal models of RLS phenotypes. Sleep Med. 31, 23-28 (2017)
7.
Garcia Borreguero, D.* ; Winkelmann, J. & Allen, R.P.*: Introduction: Towards a better understanding of the science of RLS/WED. Sleep Med. 31, 1-2 (2017)
8.
Helbig, A.K. et al.: Relationship between sleep disturbances and multimorbidity among community-dwelling men and women aged 65–93 years: Results from the KORA Age Study. Sleep Med. 33, 151-159 (2017)
9.
Salminen, A.V.* et al.: Circadian locomotor activity in meis1 knock-out mice. Sleep Med. 40, E290-E291 (2017)
10.
Winkelmann, J. et al.: Genetics of restless legs syndrome. Sleep Med. 31, 18-22 (2017)
11.
Connor, J.R.* ; Patton, S.M.* ; Oexle, K. & Allen, R.P.*: Iron and restless legs syndrome: Treatment, genetics and pathophysiology. Sleep Med., DOI: 10.1016/j.sleep.2016.07.028 (2016)
12.
García-Borreguero, D.* et al.: Guidelines for the first-line treatment of restless legs syndrome/Willis-Ekbom disease, prevention and treatment of dopaminergic augmentation: A combined task force of the IRLSSG, EURLSSG, and the RLS-foundation. Sleep Med. 21, 1-11 (2016)
13.
Schulte, E.C.* ; Gross, N.* ; Slawik, H.* & Winkelmann, J.: "Malignant restless legs syndrome" - a curse or a blessing? Sleep Med. 15, 155–156 (2014)
14.
Helbig, A.K. et al.: Association between sleep disturbances and falls among the elderly: Results from the German Cooperative Health Research in the Region of Augsburg-age study. Sleep Med. 14, 1356-1363 (2013)
15.
Schulte, E.C. ; Gross, N.* ; Slawik, H.* & Winkelmann, J.: When restless legs syndrome turns malignant. Sleep Med. 14, 575-577 (2013)
16.
Vávrová, J. et al.: Restless legs syndrome in Czech patients with multiple sclerosis: An epidemiological and genetic study. Sleep Med. 13, 848-851 (2012)
17.
García-Borreguero, D.* et al.: Diagnostic standards for dopaminergic augmentation of restless legs syndrome: Report from a World Association of Sleep Medicine-International Restless Legs Syndrome Study Group consensus conference at the Max Planck Institute. Sleep Med. 8, 520-530 (2007)